Vantage Investment Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$1K Sell
100
-150
-60% -$2.03K ﹤0.01% 725
2018
Q2
$4K Sell
250
-250
-50% -$4.32K ﹤0.01% 651
2018
Q1
$10K Hold
500
﹤0.01% 553
2017
Q4
$9K Hold
500
﹤0.01% 597
2017
Q3
$11K Buy
+500
New +$7.91K ﹤0.01% 541

Other funds holding DVAX

Vantage Investment Advisors's DVAX Position: Q3 2018 in Review

Vantage Investment Advisors reduced its Dynavax Technologies (DVAX) stake by 60% in Q3 2018, selling an estimated $2.03K and leaving 100 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #725.

Vantage Investment Advisors first reported a position in DVAX in Q3 2017 and has held it in 5 quarters since. The position peaked at $11K in Q3 2017. 150 funds tracked by Wall St. Rank hold DVAX as of Q3 2018.

  • Vantage Investment Advisors held 100 shares of Dynavax Technologies worth $1K as of Q3 2018.
  • Vantage Investment Advisors sold 150 Dynavax Technologies shares in Q3 2018, an estimated $2.03K.
  • Dynavax Technologies made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #725 holding.
  • Vantage Investment Advisors first reported a position in Dynavax Technologies in Q3 2017 and has held it in 5 quarters since.
  • Vantage Investment Advisors's Dynavax Technologies position peaked at $11K in Q3 2017.
  • 150 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2018.

Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.